| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7368477
[patent_doc_number] => 20040092589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Use of retinoic acid for treatment of autism'
[patent_app_type] => new
[patent_app_number] => 10/175919
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2247
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092589.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175919
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175919 | Use of retinoic acid for treatment of autism | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6736118
[patent_doc_number] => 20030013753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Transdermal migraine therapy'
[patent_app_type] => new
[patent_app_number] => 10/163234
[patent_app_country] => US
[patent_app_date] => 2002-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10613
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013753.pdf
[firstpage_image] =>[orig_patent_app_number] => 10163234
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/163234 | Transdermal migraine therapy | Jun 4, 2002 | Abandoned |
Array
(
[id] => 6653617
[patent_doc_number] => 20030008924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Small molecule antagonists of Bcl-2 family proteins'
[patent_app_type] => new
[patent_app_number] => 10/158769
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27716
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008924.pdf
[firstpage_image] =>[orig_patent_app_number] => 10158769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/158769 | Small molecule antagonists of Bcl-2 family proteins | May 29, 2002 | Abandoned |
Array
(
[id] => 6402850
[patent_doc_number] => 20020182239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting'
[patent_app_type] => new
[patent_app_number] => 10/148258
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6231
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10148258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/148258 | Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting | May 28, 2002 | Abandoned |
Array
(
[id] => 6800795
[patent_doc_number] => 20030095959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Topical skin composition'
[patent_app_type] => new
[patent_app_number] => 10/155305
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5032
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20030095959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155305
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155305 | Topical skin composition | May 23, 2002 | Abandoned |
Array
(
[id] => 6770486
[patent_doc_number] => 20030216426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs'
[patent_app_type] => new
[patent_app_number] => 10/150619
[patent_app_country] => US
[patent_app_date] => 2002-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5675
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20030216426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10150619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/150619 | Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs | May 16, 2002 | Abandoned |
| 10/130142 | Inhibitors of helicobacter pylori induced gastrointestinal diseases | May 15, 2002 | Abandoned |
| 10/129287 | Use of nsaids for the treatment of pancretic cancer | May 1, 2002 | Abandoned |
| 10/030886 | COMPOSITION CONTAINING CARVACROL AND THYMOL FOR USE AS A BACTERICIDE | Apr 29, 2002 | Abandoned |
Array
(
[id] => 6688853
[patent_doc_number] => 20030032578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Antifungal and antiparasitic compounds'
[patent_app_type] => new
[patent_app_number] => 10/119502
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13963
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032578.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119502 | Antifungal and antiparasitic compounds | Apr 9, 2002 | Abandoned |
Array
(
[id] => 1065716
[patent_doc_number] => 06846842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-25
[patent_title] => 'Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion'
[patent_app_type] => utility
[patent_app_number] => 10/116707
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 7095
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/846/06846842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116707 | Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion | Apr 3, 2002 | Issued |
Array
(
[id] => 5788315
[patent_doc_number] => 20020160947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Synergistic method for prolonging allograft survival'
[patent_app_type] => new
[patent_app_number] => 10/114602
[patent_app_country] => US
[patent_app_date] => 2002-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 1995
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10114602
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/114602 | Synergistic method for prolonging allograft survival | Apr 1, 2002 | Abandoned |
Array
(
[id] => 6773911
[patent_doc_number] => 20030017249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Composition for drinking/eating and beverage/food'
[patent_app_type] => new
[patent_app_number] => 10/112899
[patent_app_country] => US
[patent_app_date] => 2002-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2425
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017249.pdf
[firstpage_image] =>[orig_patent_app_number] => 10112899
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/112899 | Composition for drinking/eating and beverage/food | Mar 31, 2002 | Issued |
Array
(
[id] => 6546314
[patent_doc_number] => 20020137772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Treatment of diabetes with thiazolidinedione and metformin'
[patent_app_type] => new
[patent_app_number] => 10/099161
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3608
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137772.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099161 | Treatment of diabetes with thiazolidinedione and metformin | Mar 12, 2002 | Abandoned |
Array
(
[id] => 6329428
[patent_doc_number] => 20020198185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Method of enhancing reproductive performance in sows'
[patent_app_type] => new
[patent_app_number] => 10/087198
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5667
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087198
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087198 | Method of enhancing reproductive performance in sows | Feb 28, 2002 | Issued |
Array
(
[id] => 1220942
[patent_doc_number] => 06703424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-09
[patent_title] => 'Dispersible compositions containing L-DOPA ethyl ester'
[patent_app_type] => B2
[patent_app_number] => 10/083959
[patent_app_country] => US
[patent_app_date] => 2002-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8197
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/703/06703424.pdf
[firstpage_image] =>[orig_patent_app_number] => 10083959
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/083959 | Dispersible compositions containing L-DOPA ethyl ester | Feb 24, 2002 | Issued |
Array
(
[id] => 6112488
[patent_doc_number] => 20020173447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Cytostatic effects of fatty acid synthase inhibition'
[patent_app_type] => new
[patent_app_number] => 10/075344
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8475
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075344 | Cytostatic effects of fatty acid synthase inhibition | Feb 14, 2002 | Abandoned |
Array
(
[id] => 6751061
[patent_doc_number] => 20030045582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Method for treating hyperglycemia'
[patent_app_type] => new
[patent_app_number] => 10/071851
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5427
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045582.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071851
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071851 | Method for treating hyperglycemia | Feb 7, 2002 | Abandoned |
| 10/071733 | Combination therapy for treatment of schizophrenia | Feb 7, 2002 | Abandoned |
Array
(
[id] => 6451457
[patent_doc_number] => 20020177612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Composition comprising 5-[4-[2-(N-methyl-N-2-pyridy)amino)ethoxy]benzyl]thiazolidine-2,4-dione'
[patent_app_type] => new
[patent_app_number] => 10/068514
[patent_app_country] => US
[patent_app_date] => 2002-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3318
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177612.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068514 | Composition comprising 5-[4-[2-(N-methyl-N-2-pyridy)amino)ethoxy]benzyl]thiazolidine-2,4-dione | Feb 4, 2002 | Abandoned |